Total Payments
$513,938
2024 Payments
$174.63
Companies
24
Transactions
135
Medicare Patients
5,155
Medicare Billing
$480,444
Payment Breakdown by Category
Research$499,492 (97.2%)
Consulting$6,026 (1.2%)
Food & Beverage$3,300 (0.6%)
Travel$2,770 (0.5%)
Education$2,349 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $499,492 | 44 | 97.2% |
| Consulting Fee | $6,026 | 1 | 1.2% |
| Food and Beverage | $3,300 | 81 | 0.6% |
| Travel and Lodging | $2,770 | 7 | 0.5% |
| Education | $2,349 | 2 | 0.5% |
Payments by Type
Research
$499,492
44 transactions
General
$14,446
91 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech, Inc. | $219,714 | 28 | $0 (2019) |
| Integra LifeSciences Corporation | $164,769 | 19 | $0 (2023) |
| Celgene Corporation | $115,107 | 2 | $0 (2018) |
| Celularity, Inc. | $6,439 | 6 | $0 (2019) |
| Elite Orthopedics, LLC | $1,714 | 6 | $0 (2023) |
| Mylan Specialty L.P. | $1,714 | 6 | $0 (2023) |
| Zimmer Biomet Holdings, Inc. | $1,317 | 10 | $0 (2019) |
| Arthrex, Inc. | $1,143 | 4 | $0 (2020) |
| Stryker Corporation | $833.95 | 19 | $0 (2023) |
| ETS Wound Care LLC | $304.72 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $174.63 | 8 | Averitas Pharma Inc. ($60.52) |
| 2023 | $2,132 | 19 | Mylan Specialty L.P. ($1,714) |
| 2022 | $349.55 | 6 | ETS Wound Care LLC ($233.00) |
| 2021 | $56,708 | 12 | Integra LifeSciences Corporation ($56,283) |
| 2020 | $109,986 | 23 | Integra LifeSciences Corporation ($108,431) |
| 2019 | $42,085 | 22 | Genentech, Inc. ($35,450) |
| 2018 | $221,531 | 37 | Genentech, Inc. ($184,264) |
| 2017 | $80,972 | 8 | Celgene Corporation ($79,293) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PolyNovo North America LLC | NOVOSORB BTM (Device) | Food and Beverage | In-kind items and services | $47.78 | General |
| Category: SYNTHETIC DERMAL SUBSTITUTE | ||||||
| 11/27/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: WOUND CARE | ||||||
| 10/23/2024 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: FOOT AND ANKLE | ||||||
| 10/04/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/22/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/02/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $16.97 | General |
| 11/17/2023 | Mylan Specialty L.P. | — | Travel and Lodging | In-kind items and services | $163.78 | General |
| 11/16/2023 | Mylan Specialty L.P. | — | Travel and Lodging | In-kind items and services | $978.23 | General |
| 11/16/2023 | Mylan Specialty L.P. | — | Travel and Lodging | In-kind items and services | $222.73 | General |
| 11/16/2023 | Mylan Specialty L.P. | — | Travel and Lodging | In-kind items and services | $163.78 | General |
| 11/16/2023 | Mylan Specialty L.P. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/16/2023 | Mylan Specialty L.P. | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 09/01/2023 | AXOGEN | Avance Nerve Graft (Device) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: Neurology | ||||||
| 08/30/2023 | Bioventus LLC | Exogen Ultrasound Bone Healing System (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Not Applicable | ||||||
| 08/19/2023 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/11/2023 | Stryker Corporation | 7 X 23MM CITRELOCK IMPLANT (Device) | Food and Beverage | In-kind items and services | $57.51 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 07/13/2023 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: FOOT AND ANKLE | ||||||
| 06/08/2023 | Stryker Corporation | 7 X 23MM CITRELOCK IMPLANT (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 05/05/2023 | Paragon 28, Inc. | Phantom Metatarsal Shortening (Device) | Food and Beverage | Cash or cash equivalent | $28.77 | General |
| Category: FOOT AND ANKLE IMPLANTS | ||||||
| 04/21/2023 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Recon-Skin and Wound | ||||||
| 03/06/2023 | ETS Wound Care LLC | — | Food and Beverage | Cash or cash equivalent | $71.72 | General |
| 02/11/2023 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $95.11 | General |
| Category: FOOT AND ANKLE | ||||||
| 01/17/2023 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $27.28 | General |
| Category: FOOT AND ANKLE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PH 1A B SAD MAD | Genentech, Inc. | $219,714 | 28 |
| T-PMXDFU | Integra LifeSciences Corporation | $88,879 | 8 |
| CCT-PDA-002-DFU-002 | Celgene Corporation | $79,293 | 1 |
| T-PMXDFU-01 | Integra LifeSciences Corporation | $75,792 | 6 |
| CCT-PDA-002-DFU-002 - A phase 2 multicenter, randomized, doubleblind, placebo–controlled, dose range finding study to evaluate the efficacy and safety of intramuscular injection of human placenta-derived cells (pda-002) | Celgene Corporation | $35,814 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 844 | 2,142 | $239,197 | $90,686 |
| 2022 | 18 | 1,404 | 2,744 | $308,203 | $119,338 |
| 2021 | 22 | 1,449 | 2,985 | $363,950 | $142,324 |
| 2020 | 22 | 1,458 | 2,908 | $322,603 | $128,096 |
Total Patients
5,155
Total Services
10,779
Medicare Billing
$480,444
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 313 | $45,385 | $20,404 | 45.0% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 97 | 244 | $36,535 | $13,915 | 38.1% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 81 | 280 | $23,800 | $9,228 | 38.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 17 | 90 | $27,000 | $8,554 | 31.7% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 104 | 341 | $20,460 | $8,332 | 40.7% |
| 11057 | Removal of noncancer thickened skin growth, more than 4 growths | Office | 2023 | 39 | 91 | $13,195 | $5,802 | 44.0% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 50 | 85 | $9,775 | $4,035 | 41.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 72 | 94 | $7,520 | $3,805 | 50.6% |
| G0127 | Trimming of dystrophic nails, any number | Office | 2023 | 96 | 324 | $20,088 | $3,568 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 37 | $7,918 | $3,503 | 44.2% |
| 29581 | Application of vein wound compression bandages on lower leg, ankle, and foot | Office | 2023 | 13 | 54 | $8,640 | $3,012 | 34.9% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 47 | 97 | $9,312 | $2,489 | 26.7% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 14 | 21 | $3,675 | $1,619 | 44.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $3,024 | $1,244 | 41.1% |
| 11730 | Simple separation of fingernail or toenail from nail bed, first nail | Office | 2023 | 14 | 14 | $2,800 | $1,155 | 41.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 22 | $44.00 | $18.49 | 42.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 16 | 21 | $26.25 | $2.10 | 8.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 225 | 398 | $57,710 | $26,610 | 46.1% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 136 | 287 | $43,035 | $16,779 | 39.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 164 | 387 | $32,895 | $12,768 | 38.8% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 162 | 388 | $23,280 | $9,356 | 40.2% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 26 | 84 | $25,200 | $8,063 | 32.0% |
| 11057 | Removal of noncancer thickened skin growth, more than 4 growths | Office | 2022 | 62 | 117 | $16,965 | $7,401 | 43.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 79 | 79 | $17,064 | $6,256 | 36.7% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 83 | 123 | $14,145 | $6,173 | 43.6% |
About Dr. Christopher Anderson, DPM
Dr. Christopher Anderson, DPM is a Foot Surgery healthcare provider based in O'fallon, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790760494.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Anderson, DPM has received a total of $513,938 in payments from pharmaceutical and medical device companies, with $174.63 received in 2024. These payments were reported across 135 transactions from 24 companies. The most common payment nature is "" ($499,492).
As a Medicare-enrolled provider, Anderson has provided services to 5,155 Medicare beneficiaries, totaling 10,779 services with total Medicare billing of $480,444. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot Surgery
- Other Specialties Foot Surgery
- Location O'fallon, IL
- Active Since 12/14/2005
- Last Updated 10/07/2020
- Taxonomy Code 213ES0131X
- Entity Type Individual
- NPI Number 1790760494
Products in Payments
- Non-Covered Product (Drug) $219,714
- PRIMATRIX (Device) $164,671
- PDA002 (Drug) $115,107
- Alps Small Frag (Device) $993.56
- Biovance (Biological) $313.00
- MIRRAGEN ADVANCED WOUND MATRIX (Device) $233.00
- VARIAX (Device) $203.55
- LAPIPLASTY SYSTEM (Device) $163.74
- ALLOWRAP (Device) $163.71
- Puraply Antimicrobial (Medical Supply) $157.79
- Lapidus Plate (Device) $104.16
- SCP Bone Substitute (Device) $103.37
- ANCHORAGE (Device) $87.62
- PROLAYER (Device) $81.58
- Avance Nerve Graft (Device) $79.05
- 7 X 23MM CITRELOCK IMPLANT (Device) $71.57
- AccuFill (Device) $68.53
- Affinity (Medical Supply) $61.72
- QUTENZA (Drug) $60.52
- NOVOSORB BTM (Device) $47.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.